the RT2831 project of Regenecore officially obtained IND approval by FDA
- Categories:News
- Author:
- Origin:
- Time of issue:2024-07-26
- Views:0
the RT2831 project of Regenecore officially obtained IND approval by FDA
(Summary description)On July 25th, the RT2831 project of Nanjing Regenecore officially obtained Investigational New Drug Application (IND) approval by FDA, USA. This is another major breakthrough for the Regenecore team in the field of tumor treatment after autoimmune diseases, and also the second IND approval for nanobody drugs obtained by the Regenecore team.
- Categories:News
- Author:
- Origin:
- Time of issue:2024-07-26
- Views:0
On July 25th, the RT2831 project of Nanjing Regenecore officially obtained Investigational New Drug Application (IND) approval by FDA, USA. This is another major breakthrough for the Regenecore team in the field of tumor treatment after autoimmune diseases, and also the second IND approval for nanobody drugs obtained by the Regenecore team.
Regenecore will continue to increase research and development investment, promote the RT2831 project to achieve more positive results in clinical research, and bring more blessings to cancer patients. At the same time, We will actively explore more innovative drugs and continue to move forward firmly on the path of "maintaining human health with excellent drugs".
Scan the QR code to read on your phone
TEL：
Address: Room 07 Building 16 Treehouse, No. 73, Tanmi Road, Jiangbei New District, Nanjing
Enterprise email：rjk@regenecore.com
WeChat cooperative consultation
You are the th visitor
025-58608860 
Contact 